Harold Varmus became President and Chief Executive Officer of Memorial Sloan-Kettering Cancer Center on January 1, 2000. He ended his decade-long tenure on July 1, 2010. And on July 12, 2010, Dr. Varmus took up a new role as Director of the National Cancer Institute.
On June 7 when Memorial Sloan-Kettering opened a facility housing the novel Center for Image-Guided Interventions, a suite of endoscopy rooms, and new operating rooms for the Surgical Day Hospital.
Memorial Sloan-Kettering Cancer Center's Academic Convocation honors research as it is embodied in many individuals, including students who have earned their PhD degrees for work carried out in Memorial Sloan-Ketter's laboratories, younger Memorial Sloan-Kettering physicians and scientists, and postdoctoral research fellows, as well as established clinicians and investigators from the Center and beyond.
At the 2010 Samuel and May Rudin Awards for Excellence in Nursing Ceremony, five Memorial Sloan-Kettering nurses and a nursing assistant were recognized for exemplary service in patient care.
A team of Memorial Sloan-Kettering researchers reports that prostate cancer often takes an aggressive course in patients who have inherited mutations in the genes BRCA1 or BRCA2.
A multicenter team led by Memorial Sloan-Kettering neurologist and researcher Ingo K. Mellinghoff has uncovered the relationship between two proteins that play a critical role in glioblastoma, the most common form of brain cancer.